- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Evogene (EVGN)
Evogene stock price live, this page displays TASE EVGN stock exchange data. View the EVGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Evogene real time stock price chart below.
What Is the Evogene Stock Price Today?
The Evogene stock price today is 1.280.
What Is the Stock Symbol for Evogene?
The stock symbol for Evogene is ""EVGN.""
What Stock Exchange Does Evogene Trade On?
Evogene is listed and trades on the Tel Aviv stock exchange.
Is Evogene a Good Stock to Buy?
Determining whether Evogene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVGN quote. (ISIN: IL0011050551)
What Is the Evogene Stock Price Today?
The Evogene stock price today is 1.280.
What Is the Stock Symbol for Evogene?
The stock symbol for Evogene is ""EVGN.""
What Stock Exchange Does Evogene Trade On?
Evogene is listed and trades on the Tel Aviv stock exchange.
Is Evogene a Good Stock to Buy?
Determining whether Evogene—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVGN quote. (ISIN: IL0011050551)
1.280
-0.030(-2.29%)
Closed·
Pre Market
1.2800.000(0.00%)
·
Fair Value
An estimate of a Evogene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.245
1.320
52 wk Range
0.950
5.380
EVGN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 8 days
More Info
Fair Value
An estimate of a Evogene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.2451.320
52 wk Range
0.9505.380
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EVGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Evogene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Evogene Company Profile
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Evogene Earnings Call Summary for Q1/2025
- Q1 2025 EPS of -$0.38 beat expectations, but revenue fell to $2.4M, missing forecasts; stock dropped 4.69% post-earnings
- Company focuses on AI-driven drug discovery and restructuring, including closure of Canonic operations
- Financial stability expected through end of 2026; exploring partnerships in microbiome solutions and anticipating more seed orders
- CEO emphasizes financial resilience and growing demand for castor oil; positions Evogene as pioneer in life science products
- Risks include revenue volatility, market acceptance of AI solutions, and execution risks associated with restructuring efforts
Last Updated: 21/05/2025, 15:08
Read Full TranscriptCompare EVGN to Peers and Sector
Metrics to compare | EVGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −3.9x | −0.5x | |
PEG Ratio | −0.02 | −0.05 | 0.00 | |
Price/Book | −3.0x | 2.4x | 2.6x | |
Price / LTM Sales | 1.6x | 9.4x | 3.2x | |
Upside (Analyst Target) | 173.4% | 415.0% | 41.2% | |
Fair Value Upside | Unlock | 30.4% | 6.2% | Unlock |
Earnings
Latest Release
May 21, 2025
EPS / Forecast
-0.38 / -0.73
Revenue / Forecast
2.44M / 4.00M
People Also Watch
FAQ
What Stock Exchange Does Evogene Trade On?
Evogene is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Evogene?
The stock symbol for Evogene is "EVGN."
What Is the Evogene Market Cap?
As of today, Evogene market cap is 11.04M.
What Is Evogene's Earnings Per Share (TTM)?
The Evogene EPS (TTM) is -2.48.
When Is the Next Evogene Earnings Date?
Evogene will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is EVGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Evogene Stock Split?
Evogene has split 2 times.
How Many Employees Does Evogene Have?
Evogene has 117 employees.
What is the current trading status of Evogene (EVGN)?
As of 29 Jul 2025, Evogene (EVGN) is trading at a price of 1.28, with a previous close of 1.28. The stock has fluctuated within a day range of 1.25 to 1.32, while its 52-week range spans from 0.95 to 5.38.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.